These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2013-002388-25 Phase II study to evaluate the safety and the efficacy of rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone (R-COMP 14) as front-line therapy for patients ... bad-data
Ongoing 2015-001767-40 A phase II study testing the efficacy of combined azacitidine and lenalidomide for non-M3 acute myeloid leukemia (AML) patients aged between 60 and 70 years, fit, relapsed or refractory: the AZALEA st... not-yet-due